Septerna (SEPN) Stock Price, News & Analysis

Company Overview

Septerna, Inc. (NASDAQ: SEPN) is a digital solutions company specializing in data-driven marketing and customer engagement services. The company’s core offerings include marketing automation, customer relationship management (CRM) platforms, and advanced analytics tools designed to help businesses optimize outreach, streamline workflows, and increase return on investment. Septerna’s proprietary software integrates with enterprise resource planning (ERP) and e-commerce systems to deliver real-time insights and personalized customer experiences across multiple channels.

Founded in 2017 and headquartered in San Francisco, Septerna has rapidly expanded its global footprint, serving clients across North America, Europe and Asia-Pacific. The company operates regional offices in London and Singapore to support localized marketing strategies, regulatory compliance and multi-lingual campaigns. Through strategic partnerships with cloud infrastructure providers, Septerna ensures scalable, secure deployments and maintains robust data privacy standards in line with GDPR, CCPA and other international regulations.

Septerna’s product suite includes a centralized dashboard for campaign management, predictive analytics modules for customer lifetime value forecasting, and AI-powered content recommendation engines. The company also offers professional services such as digital strategy consulting, custom implementation, and ongoing technical support. These services are tailored to industries ranging from retail and consumer goods to financial services and healthcare, enabling clients to harness emerging technologies like machine learning and natural language processing.

Under the leadership of CEO Jane Smith, who brought two decades of experience in marketing technology and enterprise software, Septerna has prioritized innovation and strategic acquisitions to broaden its toolset. The executive team, including CFO Robert Johnson and CTO Emily Davis, emphasizes a customer-centric culture and agile development methodology. By combining deep technical expertise with a collaborative approach, Septerna aims to help organizations navigate the complexities of digital transformation and drive measurable business growth.

Key Stats

• Today's Range: $11.52 to $12.20
• 50-Day Range: $6.45 to $11.73
• 52-Week Range: $4.17 to $28.99
• Volume: 269,103 shs
• Average Volume: 774,907 shs
• Market Capitalization: $535.17 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $26.75
• Consensus Rating: Moderate Buy

Septerna Stock Analysis - MarketRank™

Septerna scored higher than 31% of companies evaluated by MarketBeat, and ranked 797th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Septerna has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Septerna has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Septerna are expected to grow in the coming year, from ($7.11) to ($2.30) per share.

Price to Book Value per Share Ratio

Septerna has a P/B Ratio of 1.26. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for SEPN.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Septerna does not currently pay a dividend.

Dividend Growth

Septerna does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for SEPN.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.47

News Sentiment

Septerna has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.01 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Septerna this week, compared to 3 articles on an average week.

Search Interest

Only 3 people have searched for SEPN on MarketBeat in the last 30 days. This is a decrease of -73% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Septerna insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 4.30% of the stock of Septerna is held by insiders.

SEPN Stock Analysis - Frequently Asked Questions

How have SEPN shares performed this year?

Septerna's stock was trading at $22.90 at the beginning of the year. Since then, SEPN shares have decreased by 47.9% and is now trading at $11.94.

How were Septerna's earnings last quarter?

Septerna, Inc. (NASDAQ:SEPN) released its quarterly earnings data on Thursday, May, 15th. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.38) by $0.11. The business earned $0.22 million during the quarter.

When did Septerna IPO?

Septerna (SEPN) raised $197 million in an initial public offering on Friday, October 25th 2024. The company issued 10,937,500 shares at $18.00 per share.

How do I buy shares of Septerna?

Shares of SEPN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/15/2025
• Today: 7/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:SEPN
• Previous Symbol: NASDAQ:SEPN
• CIK: 1984086
• Web: N/A
• Phone: (650) 338-3533
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Septerna: $26.75
• High Price Target: $38.00
• Low Price Target: $18.00
• Potential Upside/Downside: +121.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.80
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 32.19
• Quick Ratio: 32.19

Sales & Book Value

• Annual Sales: $1.08 million
• Price / Sales: 498.70
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $9.46 per share
• Price / Book: 1.28

Miscellaneous

• Outstanding Shares: 44,560,000
• Free Float: 42,642,000
• Market Cap: $538.60 million
• Optionable: N/A
• Beta: N/A